Effects of Faba Bean Fractions as Ingredients in Novel Food Products on Glycemia, Appetite and Metabolic Control

Sponsor
University of Manitoba (Other)
Overall Status
Completed
CT.gov ID
NCT02666586
Collaborator
(none)
60
1
5
21.7
2.8

Study Details

Study Description

Brief Summary

To describe the effect and mechanisms of action faba bean powder and fractions (protein, starch and fiber) on glucose and insulin homeostasis, food intake, satiety and metabolic regulation in young adults (18 to 30 years).

Condition or Disease Intervention/Treatment Phase
  • Other: Faba bean powder smoothie
  • Other: Faba bean protein concentrate smoothie
  • Other: Faba bean starch smoothie
  • Other: Faba bean protein isolate smoothie
  • Other: Non-pulse smoothie smoothie
N/A

Detailed Description

The overall objective is to describe the effect and mechanisms of action of faba bean powder and fractions (protein, starch and fiber) on glucose and insulin homeostasis, food intake, satiety and metabolic regulation in young adults (18 to 30 years). The specific objectives are to test the acute effects of different faba bean ingredient smoothie on: 1) post-prandial blood glucose, appetite, satiety hormone and insulin for 200 minutes, and 2) food intake 120 minutes following consumption of the faba bean smoothie. Two short-term acute studies will be conducted to meet these objectives. Both acute studies will follow a randomized, double blinded, balanced, repeated measures design and the same protocol; except one will have an ad libitum pizza meal (study 1), while the other will have a fixed pizza meal (study 2) at 120 minutes. Half the participants will have blood drawn by IV and the other half will be finger prick.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Basic Science
Official Title:
Effects of Faba Bean Fractions as Ingredients in Novel Food Products on Glycemia, Appetite and Metabolic Control
Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Oct 21, 2017
Actual Study Completion Date :
Oct 21, 2017

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Control smoothie

Control smoothie with 32 g corn maltodextrin without added faba bean fractions.

Other: Faba bean powder smoothie
Breakfast smoothie with 32 g whole faba bean powder (300g).

Other: Faba bean protein concentrate smoothie
Breakfast smoothie with 32 g faba bean protein concentrate.

Other: Faba bean starch smoothie
Breakfast smoothie with 33 g faba bean starch.

Other: Faba bean protein isolate smoothie
Breakfast smoothie with 32 g faba bean protein isolate.

Experimental: Faba Bean powder smoothie

Breakfast smoothie with 32 g whole faba bean powder.

Other: Faba bean protein concentrate smoothie
Breakfast smoothie with 32 g faba bean protein concentrate.

Other: Faba bean starch smoothie
Breakfast smoothie with 33 g faba bean starch.

Other: Faba bean protein isolate smoothie
Breakfast smoothie with 32 g faba bean protein isolate.

Other: Non-pulse smoothie smoothie
Control smoothie with 32 g corn maltodextrin without added faba bean fractions.

Experimental: Faba bean protein concentrate smoothie

Breakfast smoothie with 32 g faba bean protein concentrate.

Other: Faba bean powder smoothie
Breakfast smoothie with 32 g whole faba bean powder (300g).

Other: Faba bean starch smoothie
Breakfast smoothie with 33 g faba bean starch.

Other: Faba bean protein isolate smoothie
Breakfast smoothie with 32 g faba bean protein isolate.

Other: Non-pulse smoothie smoothie
Control smoothie with 32 g corn maltodextrin without added faba bean fractions.

Experimental: Faba bean starch smoothie

Breakfast smoothie with 33 g faba bean starch.

Other: Faba bean powder smoothie
Breakfast smoothie with 32 g whole faba bean powder (300g).

Other: Faba bean protein concentrate smoothie
Breakfast smoothie with 32 g faba bean protein concentrate.

Other: Faba bean protein isolate smoothie
Breakfast smoothie with 32 g faba bean protein isolate.

Other: Non-pulse smoothie smoothie
Control smoothie with 32 g corn maltodextrin without added faba bean fractions.

Experimental: Faba bean protein isolate smoothie

Breakfast smoothie with 32 g faba bean protein isolate.

Other: Faba bean powder smoothie
Breakfast smoothie with 32 g whole faba bean powder (300g).

Other: Faba bean protein concentrate smoothie
Breakfast smoothie with 32 g faba bean protein concentrate.

Other: Faba bean starch smoothie
Breakfast smoothie with 33 g faba bean starch.

Other: Non-pulse smoothie smoothie
Control smoothie with 32 g corn maltodextrin without added faba bean fractions.

Outcome Measures

Primary Outcome Measures

  1. blood glucose [0-200 minutes]

    measured by finger prick blood samples by glucose meters

Secondary Outcome Measures

  1. appetite [0-200 minutes]

    measured by VAS questionnaire

  2. satiety hormones [0- 200mins]

    measured by enzyme-linked immunosorbent assay (ELISA)

  3. insulin [0-200mins]

    measured by ELISA

  4. food intake [120 minutes following consumption of the faba bean smoothie]

    energy intake at ad-libitum pizza meal

  5. physical comfort [0-200 minutes]

    measured by VAS questionnaire

  6. energy/fatigue [0-200 minutes]

    measured by VAS questionaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 30 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • healthy

  • non-smoking males

  • aged 20-30 years (min/max age)

  • a body mass index between 20 and 25 kg/m2 (the range generally accepted as ideal/healthy by Health and Welfare Canada)

Exclusion Criteria:
  • individuals diagnosed with diabetes

  • those on medication

  • breakfast skippers

  • on an energy restricted diet

  • this study excludes females because appetite and blood glucose during the female menstruation cycle changes due to fluctuations in hormones

Contacts and Locations

Locations

Site City State Country Postal Code
1 Richardson Centre for Functional Foods and Nutraceuticals Winnipeg Manitoba Canada R3T 2N2

Sponsors and Collaborators

  • University of Manitoba

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Manitoba
ClinicalTrials.gov Identifier:
NCT02666586
Other Study ID Numbers:
  • B2015:110
First Posted:
Jan 28, 2016
Last Update Posted:
Aug 31, 2018
Last Verified:
Aug 1, 2018

Study Results

No Results Posted as of Aug 31, 2018